Could fewer radiation sessions be just as effective for cervical cancer?
NCT ID NCT07709650
First seen Jul 16, 2026 · Last updated Jul 17, 2026 · Updated 1 time
Summary
This phase III trial compares a shorter course of radiation therapy (hypofractionated) against the standard longer course for people with cervical cancer. Both groups also receive chemotherapy and brachytherapy. The goal is to see if the shorter schedule controls the cancer just as well while being more convenient for patients.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- hypofractionated chemoradiotherapy (radiation given in fewer, larger doses)
- What this could lead to
- If successful, this approach could offer a more convenient and equally effective treatment option for cervical cancer, reducing the number of hospital visits needed.
- What could go wrong
- This is a single phase III trial; results may not confirm that the shorter schedule is as safe or effective as the standard one, and there may be unknown long-term side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CERVIVAL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Siriraj Hospital
Bangkok Noi, Bangkok, 10700, Thailand
Contact Phone: •••-•••-•••• Email: •••••@•••••